$35M QVAR Inhaler Settlement Resolves Teva Pharmaceuticals Antitrust Lawsuit
May 6, 2026 A $35M QVAR settlement ends a class action lawsuit that alleges Teva illegally sought to block competition for its inhaler products.
Lawsuit Filings
May 6, 2026 A $35M QVAR settlement ends a class action lawsuit that alleges Teva illegally sought to block competition for its inhaler products.